Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: A cross-sectional study of 97 patients

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 2005-2010

  Bonnet, Fabrice ^a   Pineau, Jean Jacques ^a   Taupin, Jean Luc ^b   Feyler, Anne ^b   Bonarek, Mojgan ^a   De Witte, Sten ^a   Bernard, Noelle ^a   Lacoste, Denis ^a   Morlat, Philippe ^a   Beylot, Jacques ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

^b NONE

Author keywords

Autoimmunity; Cryoglobulinemia; Hepatitis C virus; Human immunodeficiency virus

Indexed keywords

ANTIGEN; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR;

ADULT; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHRONIC DISEASE; COMPLEMENT FACTOR; CRYOGLOBULINEMIA; FEMALE; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; AUTOIMMUNITY; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CRYOGLOBULINEMIA; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PROBABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0042694647     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988;239:617-22.
2. Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983;309:453-8.
3. Pallela FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Eng J Med 1998;338:853-60.
4. Berman A, Cahn P, Perez H, et al. Human immunodeficiency virus infection associated arthritis: clinical characteristics. J Rheumatol 1999;26:1158-62.
5. Johnson RM, Little JR, Storch GA. Kawasaki-like syndromes associated with human immunodeficiency virus infection. Clin Infect Dis 2001;32:1628-34.
6. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001;54:275-8.
7. Gresh J Jr, Aguilar JL, Espinoza LR, et al. Human immunodeficiency virus infection-associated dermatomyositis. J Rheumatol 1989;16:1397-8.
8. Molina JF, Citera G, Rosler D, et al. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus. J Rheumatol 1995;22:347-50.
9. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000;30:147-66.
10. Kordossis PT, Paikos S, Aroni K, et al. Prevalence of Sjogren's-like syndrome in a cohort of HIV-1 positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998;37:691-5.
11. Williams FM, Cohen PR, Jumshyd J, Reveille JD, Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. Arthritis Rheum 1998;41:863-8.
12. Chidambaram M, Stigant CE, Sugar LM, Ramesh Prasad GV. Type I membranoproliferative glomerulonephritis in an HIV-infected individual without hepatitis C co-infection. Clin Nephrol 2002;57:154-7.
13. 1994 Revised guideliness for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. MMWR 1994;43:1-21.
14. Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
15. Dimitrakopoulos AN, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999;130:226-30.
16. Kordossis T, Sipsas NV, Kontos A, Dafni U, Moutsopoulos HM. Mixed cryoglobulinemia is associated with increased risk for death, or neoplasia in HIV-1 infection. Eur J Clin Invest 2001;31:1078-82.
17. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
18. Cohen P, Roulot D, Ferriere F, et al. Prevalence of cryoglobulins and hepatitis C virus infection in HIV-infected patients. Clin Exp Rheumatol 1997;15:523-7.
19. Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 2000;79:47-56.
20. Antinori S, Galimberti L, Rusconi S, Zehender G, Esposito R, Galli M. Disappearance of cryoglobulins and remission of symptoms in a patient with HCV-associated type II mixed cryoglobulinemia after HIV-1 infection. Clin Exp Rheumatol 1995;Suppl 13:S157-9.
21. Savige JA, Chang L, Horn S, Crowe SM. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994;18:205-11.
22. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988;84:82-8.
23. Berman A, Espinoza LR, Diaz JD, et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 1988;85:59-64.
24. Libman BS, Quismorio FP, Stimmler MM. Polyarteritis nodosa-like vasculitis in human immunodeficiency virus infection. J Rheumatol 1995;22:351-5.
25. Gisselbrecht M, Cohen P, Lortholary O, et al. Human immunodeficiency virus related vasculitis. Clinical presentation of and therapeutic approach to eight cases. Ann Med Interne 1998;149:398-405.